Bill Sponsor
House Bill 6342
116th Congress(2019-2020)
SBIC Capital Infusion Act of 2020
Introduced
Introduced
Introduced in House on Mar 23, 2020
Overview
Text
Introduced
Mar 23, 2020
Latest Action
Mar 23, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6342
Congress
116
Policy Area
Commerce
Commerce
Primary focus of measure is business investment, development, regulation; small business; consumer affairs; competition and restrictive trade practices; manufacturing, distribution, retail; marketing; intellectual property. Measures concerning international competitiveness and restrictions on imports and exports may fall under Foreign Trade and International Finance policy area.
Sponsorship by Party
Democrat
Kansas
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

SBIC Capital Infusion Act of 2020

This bill provides economic assistance to small businesses affected by COVID-19 (i.e., coronavirus disease 2019), and it reestablishes the New Markets Venture Capital Program.

Specifically, the bill provides additional leverage for small business investment companies (SBICs) by requiring the Small Business Administration (SBA), when calculating the maximum amount of outstanding leverage made available to SBICs, to exclude a certain amount of outstanding leverage to small businesses affected by COVID-19. Any excluded amounts must be used solely for working capital purposes.

The bill also reestablishes the New Markets Venture Capital Program, through which the SBA, in partnership with investment companies, encourages developmental venture capital investment in small businesses located in low-income areas.

Text (1)
March 23, 2020
Actions (2)
03/23/2020
Referred to the House Committee on Small Business.
03/23/2020
Introduced in House
Public Record
Record Updated
Feb 8, 2022 11:15:18 PM